By KATIE THOMAS
A growing chorus, including the Trump administration, is calling for a rethinking of after-the-fact drug discounts that some say contribute to rising prices.
Published: July 26, 2018 at 08:00PM
from NYT Health https://ift.tt/2LUYYlG
via IFTTT
from WordPress https://ift.tt/2v8KHuD
via IFTTT
No comments:
Post a Comment